
Zolpidem is a non-benzodiazepine hypnotic of the imidazopyridine class, sold worldwide under the brand name Ambien and dozens of generics. It is the most widely prescribed sleep medication on the planet, with over 60 million prescriptions filled annually in the United States alone — a number that speaks to both the epidemic of insomnia in modern society and the remarkable commercial success of a drug that was marketed as everything benzodiazepine sleeping pills were not. Pharmacologically, zolpidem is a selective positive allosteric modulator of GABA-A receptors containing the alpha-1 subunit (the BZ1 receptor), which is the subunit most directly responsible for sedation. This selectivity was the key selling point: unlike benzodiazepines, which bind non-selectively to all GABA-A receptor subtypes and produce sedation, anxiolysis, muscle relaxation, and anticonvulsant effects in roughly equal measure, zolpidem was supposed to provide pure, clean sedation without the baggage. The clinical reality turned out to be considerably more complicated and considerably stranger. Zolpidem is perhaps best known not for putting people to sleep but for what it does to people who fight the sleep — or who do things without any conscious awareness that they are doing them. The drug has been associated with an extraordinary catalogue of complex sleep behaviors: sleep-driving (getting in a car and driving with no memory of doing so), sleep-eating (consuming entire meals or bizarre food combinations), sleep-shopping (placing Amazon orders), sleep-texting (sending incomprehensible messages), and sleep-sex. These parasomnias are not rare edge cases — they are frequent enough that the FDA has issued multiple safety communications and, in 2013, took the unusual step of halving the recommended dose for women from 10mg to 5mg after pharmacokinetic data showed that women metabolize zolpidem more slowly, resulting in higher next-morning blood levels and increased risk of impaired driving. The internet christened the phenomenon the "Ambien walrus" — a darkly humorous meme personifying the drug's tendency to lead users into bizarre, regrettable, and completely amnestic behaviors. Beyond the parasomnia issue, zolpidem is a genuinely addictive substance that produces physical dependence within 2-4 weeks of nightly use, triggers rebound insomnia upon discontinuation that is often worse than the original sleep problem, and has recreational potential that its original marketing conspicuously underplayed.